Search

everythinglearnresearchcommunity

for

Search:↓

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Testosterone's effects on COVID-19 are unclear and need more research.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Monocytes might be linked to hair loss after COVID-19.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

COVID-19 infection may cause hair loss a few months after recovery.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

COVID-19 can cause various skin symptoms that usually improve with proper treatment.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.